Blepharitis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
No predilection towards either gender exists. However, [[staphylococcal]] are commonly often observed among females than males. | No predilection towards either gender exists. However, [[staphylococcal]] are commonly often observed among females than males. | ||
===Developed Countries=== | ===Developed Countries=== | ||
In developed countries/United States, blepharitis more than 25 million people. In a survey [[ophthalmologists]] and optometrists report that blepharitis is commonly seen in clinical practice | In developed countries/United States, blepharitis more than 25 million people. In a survey [[ophthalmologists]] and optometrists report that blepharitis is commonly seen in clinical practice ranges a low of 37.000 per 100,00 patients, to a high of 47,000 per 100,000 patients.<ref name="pmid19383269">{{cite journal| author=Lemp MA, Nichols KK| title=Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. | journal=Ocul Surf | year= 2009 | volume= 7 | issue= 2 Suppl | pages= S1-S14 | pmid=19383269 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19383269 }} </ref> | ||
===Developing Countries=== | ===Developing Countries=== | ||
Revision as of 16:33, 12 July 2016
|
Blepharitis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Blepharitis epidemiology and demographics On the Web | |
|
American Roentgen Ray Society Images of Blepharitis epidemiology and demographics | |
|
Risk calculators and risk factors for Blepharitis epidemiology and demographics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Blepharitis is one of the most common ocular disorders encountered in clinical practice. Up to 20,000 per 100,000 adults over the age of 45 report some discomfort from blepharitis and meibomian gland dysfunction (MGD).[1]
Epidemiology and Demographics
Prevalence
Incidence
Age
Blepharitis can affect all age groups. Chronic blepharitis tends to affect middle age population. (50 years old). Staphylococcal blepharitis ends to affect relatively younger population. (42 years old)
Gender
No predilection towards either gender exists. However, staphylococcal are commonly often observed among females than males.
Developed Countries
In developed countries/United States, blepharitis more than 25 million people. In a survey ophthalmologists and optometrists report that blepharitis is commonly seen in clinical practice ranges a low of 37.000 per 100,00 patients, to a high of 47,000 per 100,000 patients.[2]
Developing Countries
References
- ↑ Macsai MS (2008). "The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)". Trans Am Ophthalmol Soc. 106: 336–56. PMC 2646454. PMID 19277245.
- ↑ Lemp MA, Nichols KK (2009). "Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment". Ocul Surf. 7 (2 Suppl): S1–S14. PMID 19383269.